Catalase is a ubiquitous antioxidant enzyme found in all organisms. The main task for catalase is to catalyze the decomposition of hydrogen peroxide to water and oxygen. Several rare polymorphisms have been found in the catalase gene. Most of them are associated with acatalasemia. A common C>T exchange, -262 bp from the transcription start site, influences promoter activity and blood catalase levels. A C>T exchange at -844 in the promoter has been associated with hypertension in Chinese individuals. The human catalase gene consists of 13 exams and is located on chromosome 11p13. The human catalase promoter lacks a TATA-box but contains 3 GCboxes and 5 CCAAT-boxes. The GC-and CCAAT-boxes generally work as promoter signals in many eukaryotic cells. The Sptranscription factor family recognises GC-boxes while the CCAAT-boxes are recognised by transcription factors such as NF-Y. Deletion analysis of the human catalase promoter showed that a region containing 2 GC-boxes and 5 CCAATboxes is necessary for basal transcription. Sitedirected mutagenesis was used to mutate the GCand CCAAT elements.
Catalase is a ubiquitous antioxidant enzyme found in all organisms. The main task for catalase is to catalyze the decomposition of hydrogen peroxide to water and oxygen. Several rare polymorphisms have been found in the catalase gene. Most of them are associated with acatalasemia. A common C>T exchange, -262 bp from the transcription start site, influences promoter activity and blood catalase levels. A C>T exchange at -844 in the promoter has been associated with hypertension in Chinese individuals. The human catalase gene consists of 13 exams and is located on chromosome 11p13. The human catalase promoter lacks a TATA-box but contains 3 GCboxes and 5 CCAAT-boxes. The GC-and CCAAT-boxes generally work as promoter signals in many eukaryotic cells. The Sptranscription factor family recognises GC-boxes while the CCAAT-boxes are recognised by transcription factors such as NF-Y. Deletion analysis of the human catalase promoter showed that a region containing 2 GC-boxes and 5 CCAATboxes is necessary for basal transcription. Sitedirected mutagenesis was used to mutate the GCand CCAAT elements.
Expression studies with reporter constructs showed that mutated GC-boxes give increased promoter activity. Expression studies with reporter constructs containing mutated CCAATboxes also influence promoter activity. Mutation of CCAAT-box 92 results in a complete lack of activity. Leading us to conclude that CCAATbox 92 is necessary for the basal expression of the human catalase gene in HepG2 cells. EMSA analysis showed that transcription factor NF-Y binds to the CCAAT-box. To establish the mechanism of differential promoter activity we are currently investigating whether negative regulation via an upstream GC box is influenced by the 262 C/T promoter polymorphism. oxidation, the breakdown of mitochondrial DNA and inhibition of the respiratory chain. We proposed that some etiological mutations of the genes, encoding antioxidant scavenging enzymes can be involved in the genetic susceptibility to DPN in patients with type 1 diabetes mellitus (T1D). We studied an association with DPN of some polymorphic markers located in such candidate genes: Ala (-9) Val of mitochondrial superoxide dismutase gene (SOD2), Arg213Gly of extracellular superoxide dismutase gene (SOD3), C1167T and T(-262)C of catalase gene (CAT) and Pro197Leu of glutathione peroxidase gene (GPX1), +/0 of glutation-S-transferase T (GSTT1) and glutation-S-transferase M genes (GSTM1). The groups (total 180 patients) had no overlapping (polar) phenotypes. Group DPN+ included 86 patients with DPN and diabetic record no more than 5 years. Control group DPNincluded patients without DPN and diabetic record of at least 10 years. Using PCR protocols, higher frequencies of SOD2 allele Val and genotype Val/Val and of SOD3 allele Arg and genotype Arg/Arg were established for group DPN+. In case of polymorphic marker T(-262)C of CAT gene the carriers of C allele had higher risk of DPN development. No association were observed in these groups for other polymorphic markers. In conclusion, the association of antioxidant enzymes with the progression of DPN is evidence for an initial role of oxidative stress in the development of DPN.
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Human glutathione S-transferase polymorphisms modify the relation of methylmercury to fish intake
Hipolito Custodio, Karin Broberg and Staffan Skerfving Department of Occupational and Environmental Medicine, Lund University, Sweden Introduction: Fish ingestion is the predominant source of the neurotoxin methylmercury. Methylmercury is eliminated through glutathione conjugation, and since glutathione S-transferases (GST) catalyze glutathione conjugation, these enzymes might be involved in methylmercury elimination. GSTs are polymorphic in humans; hence, polymorphisms of these genes could be associated with different elimination rates. Methodology: Erythrocyte mercury concentration (EryHg), plasma polyunsaturated fatty acids (PPUFA), and fish intake were measured from 365 Swedish individuals. DNA was collected for genotype analysis. Substitution genotypes in the promoter region of GSTA1 and the coding region of GSTP1 were analyzed using real-time PCR. Deletion genotypes for GSTM1 and GSTT1 were analyzed using multiplex PCR. The study individuals were grouped according to genotype, and a general linear model was used to determine if the genotype affected the slope of the regression of EryHg on PPUFA, and the regression of EryHg on fish intake. Results: GSTP1 polymorphism is associated with a steeper slope in the regression of EryHg on both PPUFA and fish intake, particularly when the homozygous GSTP1-105 valine/valine genotype occurs in combination with at least one valine allele for GSTP1-114. This is consistent with slower methylmercury elimination in these genotypes. No similar trends were shown for GSTA1, GSTM1 or GSTT1. Discussion: These results indicate that GSTP1 may play a role in conjugating methylmercury with glutathione, and that the variant genotype group has approximately 2.6-times longer elimination half-life than usual. This is not, however, expected to translate into an increased risk of prenatal effects, since the predicted EryHg at the 97.5th percentile fish intake for this group (13.1 µg/L) remains below the levels associated with the provisional tolerable weekly intake.
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Effects of CYP2A6 polymorphism on nicotine metabolism and smoking habit We have developed a convenient and specific CYP2A6 genotyping method. Among 252 Japanese persons genotyped, 10 were genotyped as homozygous deletion (CYP2A6*4/*4). Since experiments with recombinant human cytochrome P450 enzymes in baculoviorus systems had revealed that CYP2A6 had the highest nicotine Coxidation activities, nicotine metabolism in the CYP2A6*4/*4 subjects was studied. Urinary cotinine, a principal metabolite of nicotine, was analyzed subsequent to smoking among 11 volunteers. Cumulated urinary cotinine excretion in the CYP2A6*4/*4 individuals was about one seventh compared to the control group (CYP2A6*1-positive). Cotinine levels in morning spot urine specimens from 190 healthy men were also analyzed by HPLC. The number of cigarettes smoked and CYP2A6 polymorphism were significantly associated with urinary cotinine levels. In particular, the urinary cotinine levels of smokers who were CYP2A6-deleted homozygous were drastically lower than those of the CYP2A6*1 allele possessed. The relation between CYP2A6 genotype and smoking behavior was studied among 649 healthy male subjects. The CYP2A6*4/*4 individuals may have a decreased risk of becoming smokers. They smoke less number of cigarettes and absorb less nicotine. Furthermore, there is evidence that the smokers who lack CYP2A6 are difficult to stop smoking. further by studying the XRCC3 intron 5 A>G polymorphism, which has previously been reported to have a protective effect towards breast cancer. Odds ratios (ORs) and 95 % confidence intervals (CIs) were estimated by unconditional logistic regression after adjustment by age. Our preliminary statistical evaluations revealed no significant overall association between the XRCC3 intron 5 polymorphism and breast cancer risk (OR 1.07, 95% CI 0.81-1.41). However, a statistically significant interaction was found with body mass index (BMI) (p for interaction = 0.046); women who had BMI less than 25.4 and carried at least one variant G allele were found to be at somewhat increased risk for breast cancer (OR 1.46, . Similarly, women who had ever used HRT and carried at least one variant G allele had a tendency for increased risk for breast cancer (OR 1.63, 95% CI 0.93-2.84). No association was found when stratified by the use of alcohol or tobacco. The results suggest that XRCC3 intron 5 A>G polymorphism may be a modest modifier of individual breast cancer risk in Finnish women. This work was supported by the Acad-The role of CYP1A1, GSTM1, GSTT1, mEH, and NAT2 genotypes in susceptibility to malignant mesothelioma (MM) was examined in two casecontrol studies, one conducted in Italy, one in Finland. Fifty-six asbestos exposed MM patients and 255 controls were recruited in Italy, 48 cases and 123 controls in Finland. NAT2 fast acetylator and low mEH activity genotypes were positively associated with MM in Italy, while they were negatively associated with MM in Finland. A combined effect was also observed in Italy for NAT2 fast acetylator and mEH low activity genotypes (compared to NAT2 slow acetylator and high mEH activity genotype combination, OR 3.5, 95% CI 0.9-14.8, p for trend among the six combinations = 0.007), while this combination was protective in Finland (OR 0.6, 95% CI 0.0-3.3, p for trend = 0.06). Combination of NAT2 fast acetylator and GSTM1 null genotype posed a significantly increased risk of MM (OR 2.4, 95% CI 1.0-5.7) compared to combination of NAT2 slow acetylator and functional GSTM1 genotype in the Italian, but not in the Finnish study. Glutathione S-transferases (GSTs) are involved in detoxification of carcinogens, e.g. from tobacco smoke. Therefore, polymorphisms in the GST genes have been considered as potential modifiers of individual cancer risk. In a population-based case-cohort study where cases and the sub-cohort sample were matched on duration of smoking, we investigated the occurrence of lung cancer and histological subtypes of lung cancer in relation to deletion polymorphism in both GSTM1 and GSTT1, single nucleotide polymorphisms (SNPs) in GSTP1 (Ile105Val and Ala114Val), and a three base pair deletion polymorphism in GSTM3. We further investigated the effects of the GST polymorphisms on lung cancer risk within subgroups of subjects defined by gender and age. The results showed a 2.4-fold (CI = 1.31-4.41) increased risk of lung cancer in GSTT1 null-genotype carriers, but no significant effects of the polymorphisms in GSTM1, GSTM3, GSTP1-105 or GSTP1-114. The association was strongest in lower age groups, with a 9.6-fold increase in risk for subjects with the GSTT1 nullgenotype in the 50-55 years age interval (CI = 3.03-30.59). Positive associations were found for GSTT1 within all major histological subtypes. Squamous cell carcinoma was the histological type most strongly associated with the GSTT1 genotype, with a 5.0-fold (CI = 2.26-11.18) increase in risk for subjects carrying the GSTT1 null-genotype. Lung cancer mortality rate is the highest of the world in Hungary among men. The reasons have not been understood yet. Within the framework of a multi-endpoint multicenter ongoing study, the aim of the present study was to investigate the risk of GST genetic polymorphisms for smokingrelated lung cancer in the country. The study population comprised a total of 1100 primary lung cancer cases and 340 hospital-based noncancer controls. The major histological types of lung cancer were squamous cell carcinoma (35.1%), adenocarcinoma (36.8%), small-cell (6.7%), and large-cell carcinoma (3.9%). Information on smoking was obtained with informed consent from the subjects in a questionnaire. GSTM1, GSTT1 and GSTP1 Ile105Val genotypes were determined from normal bronchial tissue or peripheral blood. Statistical analyses were performed by STATA 7.0. GSTP1 Val/Val genotype was associated with increased risk for squamous cell carcinoma among ever-smoking men (OD 1.93, p=0.06) . GSTM1 homozygous deletion genotype slightly increased the risk for squamous cell carcinoma among eversmoking men (OD 1.26, CI 0.77-2.04), and remarkably for adenocarcinoma among neversmoking men (OD 3.49, Chromosomal aberrations (CAs) and sister chromatid exchanges (SCEs) in peripheral lymphocytes are widely used as cytogenetic biomarkers of genotoxic effects. International cohort studies have linked elevated levels of CAs to cancer predisposition. The observed association between CAs and cancer might reflect individual susceptibility. We assessed the effects of genetic polymorphisms of DNA repair proteins and xenobiotic-metabolizing enzymes (XME) on the levels of CAs and SCEs in peripheral lymphocytes of 145 healthy individuals from Finland and Hungary. Genotypes of DNA repair genes XRCC1 and XRCC3 and XME genes glutathione Stransferase M1 (GSTM1) and T1 (GSTT1) and Nacetyltransferase 2 (NAT2) were determined from leukocyte DNA using polymerase chain reaction and restriction fragment length polymorphism. In linear regression models adjusting for age, sex, smoking, and genotypes, none of the polymorphic genes significantly affected the frequency of SCEs. After Poisson regression adjustment for age, sex, smoking, and genotypes, a higher level of chromosome breaks was observed in subjects homozygous for GSTT1 gene deletion (RR=2.45, 95% CI=1.32-4.35), slow NAT2 acetylators (RR=1.69, 95% CI=1.02-2.90), and individuals homozygous for XRCC1 codon 280 wild-type allele (RR=2.43, 95% CI=1.05-7.14). Our results agree with earlier findings on the influence of GSTT1 and NAT2 polymorphisms on lymphocyte chromosome damage and suggest that XRCC1 codon 280 polymorphism affects DNA repair phenotype. It is presently unclear whether these or other genetic polymorphisms could explain the observed cancer risk predictivity of high CA frequency.
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Genetic polymorphisms in DNA repair and folate metabolism and their possible links with chromosomal aberrations
Iiris Heilimo, Päivi Siivola, Heidi Maunu, Hilkka Järventaus, Katja Mitrunen, Ari Hirvonen and Hannu Norppa Laboratory of Molecular and Cellular Toxicology, Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Finland The relevance of chromosomal aberration (CA) level as an indicator of cancer predisposition has been supported by epidemiological studies suggesting that a high frequency of CAs is predictive of an increased risk of cancer. The cancer risk predictivity of CAs was not explained by tobacco smoking or occupational carcinogen exposure and did not depend on the time between CA analysis and cancer detection, indicating that the association also concerns "unexposed" subjects but does not reflect undetected cancer. The findings suggest a role for individual susceptibility to chromosome damage. In particular, variation in DNA repair capacity, possibly related to polymorphisms of DNA repair proteins, might provide an explanation. Several of such polymorphisms have been proposed to be associated with an increased cancer risk. However, very little is known about their effects on cytogenetic biomarkers in humans. In the present study, we have examined a population of 170 occupationally unexposed Finnish subjects. We have genotyped major genetic polymorphisms in DNA repair genes XRCC1 (codons 194, 280 We studied the influence of various DNA repair gene variants on the frequency of chromosomal aberrations (CAs) in subjects exposed to residential radon. A group of 84 non-smoking, healthy individuals exposed to domestic radon were analysed using the fluorescence in-situ hybridization (FISH) technique. No association between radon concentration and CA frequencies was observed.
However, a significant increase in CAs with age and a large variability in translocation frequencies between individuals within the same age group was shown. In order to investigate the role of individual susceptibility in this variation, genotypes of DNA repair genes XRCC1 (X-ray repair cross-complementing group 1; codons 194, 280 and 399), XRCC3 (X-ray repair crosscomplementing group 3; codon 241), and hOGG1 (human homologue of the yeast OGG1gene; codon 326) were determined. The in vitro adaptive response (AR) of human lymphocytes to ionizing radiation is a variable traits. Few studies have address the question weather the occupational exposure to low level of ionizing radiation might induce a similar adaptive response or not. None of them have considered the possible influence of genetic polymorphism in DNA repair enzymes on the observed variability. We have used the micronucleus assay to evaluate the adaptive ability in lymphocytes of radiological workers and the possible influence of polymorphism in the XRCC1, XRCC3 and XPD genes. The presence of AR was assessed by treating the lymphocytes with a challenge dose of 12,5 µg/ml of bleomycin (BLM), delivered at 48 h of cultivation. BLM treatment resulted in an average increase of MN frequency of 170% in controls and 108% in radiological workers [15.86 ± 5.84 and 17.95 ± 2.78 respectively]. Lymphocytes of radiological workers were less responsive to the challenge treatment with BLM as compared to controls. The hypothesized influence by genotype distribution in DNA repair genes revealed that the XRCC1-399 and XRCC3-241 variants as well the common alleles in codon 312 and 751 of the XPD gene were associated with an higher average increase of MN frequencies, although the differences were not statistically significant. Our preliminary results provide evidence supporting that the heterogeneity described in the AR may be influenced by genetic polymorphism.
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Characterisation of tissue distribution and genetic polymorphism of CYP2S1 CYP2S1 is a new member of the cytochrome P450 superfamily. Interestingly, it exhibits many features typical to CYP1 family members, e.g. dioxin-inducibility mediated by aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor nuclear translocator (ARNT). CYP2S1 has also been shown to metabolise some aromatic hydrocarbons as well as retinoic acid, suggesting a role in metabolism of both exogenous and endogenous compounds. CYP2S1 has low expression level in the liver, but is highly and constitutively expressed in many extrahepatic tissues. Our studies using in situ hybridization and immunohistochemisty show that CYP2S1 expression is strong especially in the epithelia exposed to xenobiotics, e.g. respiratory tract, gastrointestinal tract, urinary bladder and skin. High expression levels were also detected in the placenta. With respect to carcinogen metabolism, the epithelial expression is interesting, as epithelial cells also constitute common progenitor cells to tumour development. Indeed, CYP2S1 showed strong expression in many tumours of epithelial origin. Interindividual variation in CYP2S1 expression was detected in some tissues. This may be due to differential exposure to CYP2S1 inducers or it could be caused by polymorphism(s) affecting expression of CYP2S1. In our preliminary Northern blotting experiments with placental samples, no major differences were observed in CYP2S1 expression between smokers and non-smokers. Systematic investigation of the genetic variation of CYP2S1 in Finnish Caucasians revealed eight single nucleotide polymorphisms (SNPs) comprising nine different alleles (haplotypes). The most common variant allele was CYP2S1*1H harboring a substitution in the 3' untranslated region (23.8%). The two alleles, CYP2S1*2 and CYP2S1*3, which carry non-conservative amino acid substitutions, i.e. Arg 380 Cys and Pro 466 Leu, had relatively low frequencies in the Finnish study population (0.5% and 3.75%, respectively). Studies investigating the functional effect of these genetic polymorphisms are underway. PCR-RFLP based methods were developed for genotyping purposes.
Our work was financially supported by the Academy of Finland (52276) CYP2S1 is a newly discovered cytochrome P450 gene, which exhibits many features typical to CYP1 family members. CYP2S1 is mainly expressed in extrahepatic tissues, including epithelial cells of bronchus, and metabolises some aromatic hydrocarbons. Genetic variants of CYP2S1 have recently been identified (Saarikoski et al., Mutat Res, in press ). We hypothesize that genetic polymorphism of CYP2S1 may have an impact on the activation of tobacco-smoke carcinogens, thus may influence carcinogen-DNA adduct formation in the lung. Within the framework of an ongoing study we investigated the relationships between CYP2S1 genotypes and bulky DNA adducts from normal bronchial samples of 211 Hungarian lung cancer patients who underwent lung resection. CYP2S1 genotypes were determined by PCR-RFLP methods. Bulky DNA adducts were determined by 32 P-postlabelling. Genotype distribution within the whole population was 56.4% *1A/*1A, 34.1% *1A/*1H, 6.6% *1H/*1H, 1.9% *1A/*3, 0.9% *1H/*3, and 0% *3/*3. These results are in line with the frequencies observed in Finnish Caucasians. There was no statistically significant difference in levels of bulky DNA adducts among the subgroups with the three most frequent genotype variants either among smokers or non-smokers. There was no statistically significant difference in daily cigarette dose-dependent adduct formation within those three genotype groups. In combination with the Val allele of CYP1B1 Leu432Val gene polymorphism, smoking subjects with *1A/*1H genotype had significantly higher level of bronchial DNA adducts than smoking *1A/*1A subjects (p=0.002). The role of CYP2S1 as potential genetic susceptibility factor for lung cancer will be further studied in larger study population. 
MOLECULAR MECHANISMS OF DISEASES
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The relationship between Arg72Pro genetic polymorphism and gene mutations of TP53 and smoking-related lung DNA adducts in a Hungarian lung cancer population TP53 tumour suppressor gene mutations are common genetic alterations in human lung cancer. The aim of the study was to investigate the associations between Arg72Pro genetic polymorphism and mutations of TP53, and smokingrelated bulky DNA adducts in Hungarian lung cancer patients who underwent lung resection. The total study population comprised 160 subjects. Arg72Pro genotype was determined by PCR-RFLP method. Bulky DNA adducts in lung tissues were determined by 32 P-postlabelling. Analyses of TP53 mutations have been completed in exons 5 to 9 and 11 for 50 tumours by DGGE and/or SSCP screening followed by DNA sequencing. The results indicate that 34% of the tumours carried p53 mutation, most frequently in exon 8 (16%), and among ever-smoking men. TP53 mutation frequency was about 2.8-fold higher in squamous cell carcinoma than in adenocarcinoma. Sequence identification of the mutations is on going and will allow us to investigate whether the pattern of TP53 mutations follows that typically found in smoking-related lung cancers. The proportion of TP53 mutation carriers was clearly smaller among the Pro/Pro genotype individuals as compared to the subjects with Arg/Arg or Arg/Pro genotype. There was no statistically significant association between levels of DNA adducts and the presence of TP53 mutations or Arg72Pro polymorphism. Further analyses are in progress to confirm the observations in a larger study population. It has long been known that risk for sino-nasal cancer (SNC) is elevated among workers in wood processing industries. The relative risks are highest, in some studies extremely high, in association to hardwood dust (oak and beech in particular) and for adenocarcinoma histology. Excess risks reported for squamous cell histology are smaller, and may also be associated with exposure to softwood dust. However, the mechanisms by which exposure to wood dust increases the risk of cancer are not clear. Many types of environmental cancer, lung cancer in particular, show mutations characteristic to causative exposures. In an on-going project, we are currently studying p53 mutations in SNCs from cases with and without occupational exposure to wood dust. Paraffin-embedded tissue (PET) samples of SNC were collected for DNA extraction and analysis in collaboration with national cancer registries in Denmark, Finland and France. The study population includes all incident cases of the cancer of the nose and paranasal sinuses (ICD7: 160) in Denmark for the years 1992 -2002 , and in Finland for 1989 -2002 . In France, due to a different study design and type of fixation (Bouin) often used in the pathology laboratories, the number of PET samples so far collected is smaller. The preliminary results show relatively frequent p53 mutations in tumours from Denmark and Finland. We also examined p53 protein expression immunohistochemistry from a subset of Finnish and French tumours in a pilot study. In addition to mutation analyses, a pathology panel will carry out a review of tumour histologies for the whole tumour collection, and industrial hygienists will assess occupational exposure histories. Supported by the EU, 5 th FP (project no. QLK4-2000-00573), and the Academy of Finland (project no. 53631). The p53 mutation is implicated in the pathogenesis of colorectal carcinomas. Furthermore the protooncogen Bcl-2 is known to inhibit p53-induced apoptosis and is expressed in some colorectal carcinomas. The aim of this study was to determine the expression profile of p53 and Bcl-2, and to correlate such molecular alterations with available clinicopathological variables. Expression of p53 and Bcl-2 proteins was determined in 37 colorectal tumor samples by immunohistochemistry using antibodies for p53 and Bcl-2, and LSAB2 detection kit. We found a significant correlation between p53 expression (p=0.001) and lack of Bcl-2 expression in our cases. The younger patients showed higher level of p53 expression than older ones (p = 0.004). Lack of p53 expression was higher in males than females (p=001). There was also a positive correlation between tumor cells differentiation with expression of p53 (p=0.001). We observed no significant association between Bcl-2 immunostaining and clinicopathological parameters. Due to key role of p53 and Bcl-2 expression in tumor progression and chemotherapeutic efficacy, our data indicate that group of patients with p53 and Bcl-2 coexpression (24.3%) would less likely benefit from available chemotherapeutic regimens (5FU + Cisplatin) and require especial attention in their treatment regimen. Our data also showed that 59.4% of patients with positive p53 were Bcl-2 negative indicating a double gene alteration that affects their response to available chemotherapies. Therefore, we recommend analysis of tumors before deciding on chemotherapeutic regimen. Fluoropyrimidines such as 5-FU is given as adjuvant treatment to patients with advanced colorectal cancer. Identification of molecular determinants of 5-FU efficacy and toxicity such as Thymidylate Synthase and Thymidine Phosphorylase are critically important for more efficient and less toxic treatment. This study was undertaken to determine the significance of TS and TP protein expression in colorectal carcinomas, and their correlation with clinicopathological findings. Protein expression was determined in 37 colorectal tumors by immunohistochemistry using antibodies for TS and TP and LSAB2 detection kit. Both markers were positive in 43.2% of tumor samples. Positive TS and TP staining were significantly correlated with malignancy grade (P=0.013). There was no significant association between TS or TP immunostaining with tumor size and location or age and gender of patients. Among different G. I. malignancies studied in our lab, we observed lower frequency of coexpression of these markers in colorectal tumors. Over expression of both TS and TP may be useful indicators in predicting the antitumor activity of 5-FU in advanced colorectal carcinoma. Our data showed that 56.8% of patients were TS and TP negative indicating gene alterations affecting the tumor biology and its response to 5-FU based chemotherapy. Therefore, we recommend immunohistochemical analysis of tumor samples for TS and TP status as a valuable tool for selection of patients who will better respond to Fluoropyrimidines based chemotherapy of cancers.
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Evidence for the breast cancer predisposing role of the NBS1 657del5 mutation in Russia The NBS1 gene contributes to a variety of the processes protecting the chromosomal stability. While its homozygous truncating germ-line mutations cause a life-threatening condition called Nijmegen chromosomal breakage syndrome (NBS), the NBS1 heterozygosity does not result in obvious clinical manifestations. However, it was suggested recently in a Polish case-control study, that the founder hypomorphic mutation in the NBS1, 657del5, which occurs in approximately 0.5% of Slavic subjects, may be associated with the increased risk of breast cancer (BC). We attempted to validate these findings in another Slavic population, Russians. To overcome the difficulties related to the low prevalence of the 657del5 variant, we involved the subject groups with presumably extreme characteristics of breast cancer risk and tolerance, such as patients with bilateral breast cancer (biBC) and elderly tumor-free women. The frequency of the NBS1 heterozygosity demonstrated a trend towards gradual deviations from the most to the least susceptible groups of females: the 657del5 mutation was detected in 2 out of 173 (1.16%) biBC cases, 5 out of 700 (0.71%) unilateral BC patients, 2 out of 348 (0.57%) healthy middleaged females and, strikingly, in none out of 344 elderly tumor-free women. The difference between the "extreme" cohorts, i.e. biBC patients versus elderly controls, approached the formal limit of statistic significance (p = 0.046); other comparisons produced non-significant p values. In both bilateral and unilateral breast cancer cohorts, the NBS1 657del5 carriers tended to be slightly younger than non-carriers. Thus, the present report suggests that the NBS1 Slavic founder mutation may play a role in predisposition to breast cancer in Russia. Although the occurrence, and therefore the health impact of this mutation is low outside the Eastern Europe, the global-wide contribution of other NBS1 mutations in cancer incidence remains to be analyzed.
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Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: A pilot case-control study in Uganda 
Uganda Cancer Institute, Kampala, Uganda
The association between squamous-cell carcinoma of the conjunctiva (SCC) and HIV-related immune impairment indicates a possible infectious aetiology. We studied 21 SCC cases and 22 controls with benign lesions of the conjunctiva from Uganda. A broad spectrum of human papillomavirus (HPV) types was tested for using PCRbased assays. No mucosal high-risk HPV types were detected, but Epidermodysplasia verruciformis (EV) HPV types were found in 18/21 (86%) of SCC cases and 8/22 (36%) of controls (age-adjusted odds ratio=12.0: 95% confidence interval: 1.7-312). Adjustment for level of sun exposure, but not for HIV, was possible. The strong association that we found points to a possible role of EV HPVs in the aetiology of SCC. A mouse model of FAS was used to investigate the effect of alcohol on fetal brain mitochondria development and the relationship to born defects of CNS. Histological examination, flow cytometry and biochemical analysis disclosed significant changes of the fetal brain mitochondria in alcohol exposure groups. The mitochondria were generally less mature and were reduced in quantity. ATP accumulation in the mitochondrial matrix was less. The activities of respiratory chain complex I, IV and ATP synthase were significantly down regulated, which resulted in low energy status of whole cells in development. At the end of the research, a new clue to the mechanism of alcohol's teratogenic action on fetal brain was drawn, of which mitochondria was the initial affected tache.
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Telomeres are repetitive sequences at the ends of eukaryotic chromosomes. The telomeres protect the chromosomes from degradation and fusion, and lack of functional telomeres can cause chromosomal aberrations. This type of genetic instability can promote tumorigenesis. It is known that there is a genetic variation in telomere length in the population, independent of age and sex. We have investigated the association between telomere length and bladder cancer risk in a casecontrol study. The telomere length from the study participants was established from buccal cells with quantitative PCR. Patients with bladder cancer displayed shorter telomeres than the controls. It is known that oxidative stress effects shortening of telomeres. Thus, we are also analyzing whether different factors associated with oxidative stress, like smoking, occupational exposure, or polymorphisms in oxidative stress-related genes can modify the association between telomere length and cancer risk. The results from this study will elucidate the importance of telomere length as a marker for bladder cancer risk.
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Genetic variations in GSTM1, nucleotide excision repair and apoptotic capacity on anti-BPDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed cokeoven workers We evaluated the polymorphisms of nucleotide excision repair (NER) genes (XPC-PAT +/-, XPA 5' non-coding region -A23G, XPD-exon 23 A35931C Lys751Gln, XPD-exon 10 G23591A Asp312Asn), glutathione S-transferase µ 1 (GSTM1-active or -null) and Fas-A670G (also know as Apo1/CD95 one of the most important genes involved in the apoptotic pathway) on antibenzo[a]pyrenediolepoxide (BPDE)-DNA adduct levels from the lympho-monocytes (LMF) of highly PAH-exposed coke oven workers. The sample cohort included 67 male Polish coke-oven workers all belonging to the high exposure group (individual urinary post-shift 1-pyrenol >2.28 µmol/mol creatinine, the proposed BEI). The bulky anti-BPDE-DNA adduct levels were detected by HPLC/fluorescence analysis and genotypes by PCR-RFLP. The low DNA repair capacity of XPC-PAT +/+ and XPA-A23A genotypes significantly (p<0.05) double up the mean anti-BPDE-DNA adduct levels. Moreover, as already reported in our previous studies DNA adducts are also strongly influenced by GSTM1 genotype. The higher frequencies of workers with unfavourable XPC-PAT +/+ and XPA-A23A NER genotypes, alone or combined with GSTM1-null belonged to the tertile with the highest adduct level (> 4.11 adducts/ 10 8 nucleotides, p<0.01). The few subjects with the unfavourable genotypic combination, XPC-PAT +/+ or XPA-A23A NER jointly to GSTM1-null and Fas A670A, all belonged to the tertile with highest adduct level. The modulation of anti-BPDE-DNA adducts in the LMF, by GSTM1-null, some low-capacity genotypes of NER and apoptotic pathway, may be considered as genetic susceptibility factors capable of modifying the individual response to PAH(BaP) genotoxic-carcinogenic exposure in coke-oven workers. Polycyclic aromatic hydrocarbons (PAHs) are widely distributed in the environment in complex mixtures such as tobacco smoke and diesel particles. After exposure via inhalation, ingestion or dermal absorption, metabolically activated PAHs can react with DNA to form covalently bound PAH-DNA adducts, that are related to their mutagenic activity. PAH adducts can be studied as biomarkers of biological effective dose in human cells. However, little is known of the predictive value of the level of adducts in terms of cancer risk. In case-control studies disease may effects the biomarker level. Until now only one prospective study (Tang et al., 2001, Cancer Res.) , with 89 lung cancer cases, has investigated the relationship between aromatic adducts level and risk of lung cancer. Among current smokers a high level of adducts was associated with an increased risk of lung cancer. In this case-cohort study, we investigate the association between bulky PAH-DNA adducts and risk of lung cancer in the large prospective population-based Danish cohort for which detailed information on smoking patterns and other lifestyle at enrolment and during the entire previous lifetime is available. This study design features pre-cancer blood samples and information on smoking patterns. Among 54,220 cohort members, 265 lung cancer cases were identified during 6 years follow up and a sub-cohort of 272 individuals was used as comparison group. Bulky adducts in buffy coat cells collected at enrolment and stored at -180° C were analysed by 32 Ppostlabelling method using the butanol enrichment procedure. The molecular epidemiology methods were used to analyze the impact of air pollution in pregnancy outcome studies in the Czech Republic. Organic compounds adsorbed to air particles (PM10) induced DNA adducts and embryotoxicity in vitro and in vivo studies. The carcinogenic polycyclic aromatic hydrocarbons (carc-PAHs) were mostly responsible for the genotoxic activity, contributing to 45-50% of all DNA adducts induced by these complex mixtures. The placental bulky DNA adducts have been studied in relation to metabolic genotypes CYP1A1, EPHX, GSTM1 and NAT2, and plasma levels of cotinine and vitamins A, C, E. DNA adducts were determined by 32 P-postlabeling assay. DNA adducts in placentas were affected by air pollution, smoking, genotypes, vitamin C levels. Higher DNA adducts were observed in nonsmoking mothers delivering children with IUGR (intrauterine growth retardation). In the Pregnancy Outcome Project, an increased risk of IUGR was established for mothers who were exposed to carcPAHs > 15 ng/m 3 during the first month of gestation. Using multiple regression analysis, GSTP1, EPHX and CYP1A1 MspI genotypes decreased newborn birth weight in polluted district. CarcPAHs seem to be an important source of genotoxic and embryotoxic activities of organic mixtures associated with urban air particles. Recent studies on groups environmentally exposed to carc-PAHs implied the relationship between air pollution and DNA-PAH adducts as well as chromosomal aberrations by fluorescence in situ hybridization (FISH) in exposed subjects, which may be further modified by metabolic and DNA repair genes polymorphisms. Styrene (S) is used in the production of resins, plastics, and rubber. It is metabolized mainly in the liver to styrene-7,8-oxide (SO), its principal in vivo mutagenic metabolite. In this study we evaluated 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels in peripheral blood leukocytes of 31 workers (aged 31.6 ± 10.4, range 18-54 years) exposed to S and SO in an industry manufacturing resin products and 35 control subjects (aged 33.1 ± 11.3, range 19-57 years). External occupational exposure to S and SO was assessed by personal air sampling. At the same time 8-OHdG was determined in human peripheral blood leukocytes of workers by immunohistochemical method. Environmental monitoring enabled us to divide workers into three groups exposed to different levels of S and SO. The first group, workers equipped with personal protection devices, was exposed to levels of S 52.38 ± 18.94 mg/m 3 and of SO 117 ± 33 µg/m 3 . 8-OHdG levels were 0.64. The second group, 7 workers without individual protection devices, had exposure levels of S 4.08 ± 2.25 mg/m 3 and of SO 31±19 µg/m 3 . 8-OHdG concentrations were 0.88. The third group, 15 workers without individual protection devices, but who were not in direct contact with S and SO, was exposed to levels of S 0.23 ± 0.15 mg/m 3 and of SO 5.5 ± 3.9 µg/m 3 . 8-OHdG levels were 0.47. In the control group, 8-OHdG levels were 0.42. The highest 8-OHdG levels of the workers of the second group clearly indicates that the lack of a personal protection device causes an alteration in exposed workers. Findings showed that S and SO exposure can result in oxidative DNA damage.
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Acetylcholinesterase autoimmune antibody is another marker for myasthenia gravis In order to know whether acetylcholinesterase (AChE) autoimmune plays a role in both myasthenia gravis (MG), which is associated with antibodies directed against the nicotinic acetylcholine receptor (AChR) in 85% of patients, and Graves' disease (GD) we analysed by ELISA the ability of sera from 22 patients with MG without antibodies against AChR, 116 with GD having the antibodies against thyroglobulin (Tg), and 50 healthy controls (CR) to react with AChE from human brain and human Tg. Results showed that significantly increased anti-AChE activity was exhibited by a high proportion of MG (50%) and nearly unchanged anti-AchE activity was observed in GD (1%) sera, being similar with CR, which no anti-AChE activity was detected. AntiTg activity was detected in both MG patient (22% positive) and CR (19% positive). It suggested that AChE antibody should be another marker in MG but play no role in GD.
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Biomarker study to assess health risk in human occupationally exposed to environmental benzene Alongside the health risk to the general public, atmospheric pollution could be considered an occupational health hazard to professional groups such as traffic police, and professional drivers working in urban areas. Among the wide variety of potentially toxic chemicals present in the ambient air of urban centers, benzene raises particular concern, due to its haematoxicity and cancer risk In order to clarify the health risk in human exposed to environmental benzene we have organized a study to investigate biomarkers of exposure (personal passive samplers) early biological effect (micronuclei (MN) on peripheral lymphocytes) and susceptibility (MPO, GSTP1 and GSTT1 genotypes) both in 49 traffic police carrying on outdoor activities in high traffic area of Bologna city (32 no -smokers and 17 smokers, mean age 39.53±7.14), and 36 indoor workers enrolled as controls (23 no Breast milk is not only an important source of various nutrients, but also a source of environmental pollutants, like heavy metals. With increasing environmental pollution a heavy metal exposure assessment study is necessary. The concentrations of lead, chromium, nickel, and cobalt in human breast milk were examined in Turkish mothers to clarify the effects of these important elements for infant growth. Breast milk samples were collected from 215 mothers who resided in Istanbul, aged 17-45 years during the first 2 d of their lactation periods at the Obstetrics and Gynecology Department of the Istanbul Medical faculty of Istanbul University, between November 2000 and November 2001. The concentrations were determined by inductively -coupled plasma mass spectrometry. Data, which obtained from this cross-sectional study, were analyzed using appropriate statistical methods. The average age of the mothers was 28,84±5,88. The levels of elements that analyzed in breast milk were similar to those reported in previous reports. Women exposed environmentally or occupationally can have higher levels in their breast milk. Many factors affect the distribution of lead, chromium, nickel, and cobalt in breast milk and the health consequences to an infant. It is not clear what additional impact low-level exposure via breast milk may have on an infant born with a body burden to one of these metals. More studies on the effects of heavy metals in breast milk are necessary to clarify the effect of environmental and occupational factors. A program of breast milk monitoring would serve to provide the information needed to assess infant environmental and occupational exposures during breast-feeding and develop scientifically sound information on benefits and risks of breast-feeding.
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Low dose radiation induced non-targeted effects and the combined environmental exposures Our purpose was to study the cytotoxic and genotoxic effect of low dose alpha particle and environmental carcinogens such as toxic metals; PAHs and asbestos or its potential substitutes, alone and in different combination, to assess the contribution of non-targeted effects in environmental carcinogenesis. Human lung fibroblasts (HFL1) and epithelial cells (BEAS-2B; A549) were treated in different combination of alpha particle radiation and hazardous physical and chemical agents and assayed for cytotoxicity (MTT-assay) and for genotoxicity (mutation) and DNA damage repair (COMET-assay). To show the genomic instability induced by radiation, the plating efficiency, micronucleus frequency and apoptosis induction (TUNEL-assay) was followed through 40 generation of cell proliferation. Metal compounds (CdCl 2 ; NiCl 2 ; As 2 O 3 ) in low concentration (0,5-1µM) reduced the cytotoxicity of alpha particles, depending on the compound, incubation time, cell line treated and also low doses of radiation (mGy-s) reduced the cytotoxic effect of metals.(cross-adaptive response). Further increase in concentrations and/or doses resulted in additive cytotoxic responses. The DNA damage repair study showed that the rejoining of breaks was more efficient when the cells were treated in combination with glass fibres and low dose radiation then after each single exposure. The combined treatment of BEAS-2B cells by benzo [a] pyrene+benzo [a] antracene+chrysene enhanced the DNA adduct level, significantly (synergistic effect). The pretreatment of 10 mGy dose alpha radiation resulted in the reduction of the adduct level (adaptation). Our results suggest that the non-targeted effects i.e.: bystander effect, adaptive response, genomic instability should take into consideration in estimating the risk from complex environmental exposures. This research was supported by "Széchenyi" Hungarian NKFP-1/008/2001 grant.
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In-vitro model for the investigation of combined genotoxic effect of polycyclic aromatic hydrocarbons and alpha particles in cell culture 
